At the request of the Union Européenne des Médecins Spécialistes (UEMS), EAP is sharing a survey launched by the European Commission as part of the Impact Assessment of Directive 2005/36/EC on the Recognition of Professional Qualifications.
This study, led by the European Commission with the support of EY, aims to gather information on:
The functioning of recognition procedures
The administrative and financial costs involved
The potential benefits of further digitalisation
The findings will inform the Commission’s evaluation of how professional qualification recognition currently operates across Member States, including for medical doctors.
This initiative forms part of the European Commission–UNICEF three-year partnership to promote a comprehensive, prevention-oriented approach to children’s health
The project will result in the development of a Toolkit for Child and Adolescent Health and Mental Wellbeing Promotion, designed to support policymakers in strengthening national strategies and cross-sector collaboration.
The recognition framework directly affects the mobility of medical specialists across Europe. For paediatricians and other medical professionals, it influences:
Access to cross-border professional opportunities
The functioning of European Boards and examinations
Transparency and quality assurance in specialist training recognition
Administrative requirements for professionals and institutions
The European Commission’s understanding of the recognition system will depend significantly on the number and diversity of responses received.
We therefore strongly encourage National Medical Associations (NMAs), UEMS Sections, Divisions, Working Groups, Multidisciplinary Joint Committees, and European Boards to participate and to share this survey widely within their networks.
For further information, please contact:
Isabelle Dumaine
isabelle@uems.eu
EU Policy & Public Affairs Manager
UEMS
New ways to test high-risk medical devices.
Manufacturers of medical devices need to test their products before being allowed to market them. Specifically, they require clinical data showing their medical device is safe and efficient. In this context, the EU-funded CORE-MD project will translate expert scientific and clinical evidence on study designs for evaluating high-risk medical devices into advice for EU regulators. The project will propose how new trial designs can contribute and suggest ways to aggregate real-world data from medical device registries.
It will also conduct multidisciplinary workshops to propose a hierarchy of levels of evidence from clinical investigations, as well as educational and training objectives for all stakeholders, to build expertise in regulatory science in Europe. CORE–MD will translate expert scientific and clinical evidence on study designs for evaluating high-risk medical devices into advice for EU regulators, to achieve an appropriate balance between innovation, safety, and effectiveness. A unique collaboration between medical associations, regulatory agencies, notified bodies, academic institutions, patients’ groups, and health technology assessment agencies, will systematically review methodologies for the clinical investigation of high-risk medical devices, recommend how new trial designs can contribute, and advise on methods for aggregating real-world data from medical device registries with experience from clinical practice The consortium is led by the European Society of Cardiology and the European Federation of National Associations of Orthopaedics and Traumatology, and involves all 33 specialist medical associations that are members of the Biomedical Alliance in Europe.
